Title : Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients.

Pub. Date : 2011 May 1

PMID : 21292779






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. polyglutamine ataxin 2 Homo sapiens
2 We recently identified intermediate-length polyglutamine (polyQ) expansions (27-33 Qs) in ataxin 2 as a genetic risk factor for sporadic ALS in North American ALS patients. polyglutamine ataxin 2 Homo sapiens
3 We recently identified intermediate-length polyglutamine (polyQ) expansions (27-33 Qs) in ataxin 2 as a genetic risk factor for sporadic ALS in North American ALS patients. polyglutamine ataxin 2 Homo sapiens
4 To extend these findings, we assessed the ataxin 2 polyQ repeat length in 1294 European ALS patients and 679 matched healthy controls. polyglutamine ataxin 2 Homo sapiens
5 Our findings support the hypothesis that ataxin 2 plays an important role in predisposing to ALS and that polyQ expansions in ataxin 2 are a significant risk factor for the disease. polyglutamine ataxin 2 Homo sapiens